Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
If you have a history of pancreatitis or severe gastrointestinal disease, GLP-1 receptor agonists may not be appropriate
Severe kidney disease, where dosing should be monitored because the kidneys clear excess B12
Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis
The model was first fitted to the training concentrations (37.5 and 25 M doxorubicin), and then used to simulate the test concentrations (50, 12.5 and 10 M doxorubicin) as a means of blind validation, showing good accordance between the experimental and in silico outputs for all concentrations of doxorubicin
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
